Literature DB >> 15081392

VR1-, VRL-1- and P2X3 receptor-immunoreactive innervation of the rat temporomandibular joint.

H Ichikawa1, T Fukunaga, H W Jin, M Fujita, T Takano-Yamamoto, T Sugimoto.   

Abstract

Immunohistochemistry for vanilloid receptor subtype 1 (VR1), vanilloid receptor 1-like receptor (VRL-1) and P2X3 receptor was performed in the rat temporomandibular joint (TMJ). Blood vessels in the articular disk and capsule, the synovial membrane and the fibrous tissue around the condylar process were innervated by VR1- or P2X3 receptor-immunoreactive (ir) nerve fibers. However, VRL-1-immunoreactivity (ir) could not be detected in the TMJ. Retrograde tracing and immunohistochemical methods revealed that 25%, 41% and 52% of TMJ neurons in the trigeminal ganglion (TG) exhibited VR1-, VRL-1- and P2X3 receptor-ir, respectively. VR1-ir TMJ neurons were mostly small to medium-sized, whereas VRL-1- and P2X3 receptor-ir TMJ neurons were predominantly medium-sized to large. In addition, 73%, 28% and 44% of VR1-, VRL-1- and P2X3 receptor-ir TMJ neurons, respectively, coexpressed calcitonin gene-related peptide (CGRP)-ir. The present study suggests that the TMJ has abundant nociceptors which respond to vanilloid compounds, protons, heat and extracellular ATP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081392     DOI: 10.1016/j.brainres.2004.02.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  P2X and NMDA receptor involvement in temporomandibular joint-evoked reflex activity in rat jaw muscles.

Authors:  T Watanabe; Y Tsuboi; B J Sessle; K Iwata; J W Hu
Journal:  Brain Res       Date:  2010-05-23       Impact factor: 3.252

Review 2.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

3.  Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons.

Authors:  V Staikopoulos; B J Sessle; J B Furness; E A Jennings
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

4.  Dense transient receptor potential cation channel, vanilloid family, type 2 (TRPV2) immunoreactivity defines a subset of motoneurons in the dorsal lateral nucleus of the spinal cord, the nucleus ambiguus and the trigeminal motor nucleus in rat.

Authors:  R D Lewinter; G Scherrer; A I Basbaum
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

Review 5.  Inflammation, pain, and pressure--purinergic signaling in oral tissues.

Authors:  J C Lim; C H Mitchell
Journal:  J Dent Res       Date:  2012-10-04       Impact factor: 6.116

6.  Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract.

Authors:  Marcie J Abbey; Vinit V Patil; Carrie V Vause; Paul L Durham
Journal:  J Ethnopharmacol       Date:  2007-10-05       Impact factor: 4.360

7.  TRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP.

Authors:  Marina Quartu; Maria Pina Serra; Marianna Boi; Laura Poddighe; Cristina Picci; Roberto Demontis; Marina Del Fiacco
Journal:  J Anat       Date:  2016-07-26       Impact factor: 2.610

8.  Increased expression of CGRP in sensory afferents of arthritic mice--effect of genetic deletion of the vanilloid receptor TRPV1.

Authors:  Yong Chen; Helen H Willcockson; Juli G Valtschanoff
Journal:  Neuropeptides       Date:  2008-09-11       Impact factor: 3.286

9.  Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans.

Authors:  L Arendt-Nielsen; P Svensson; B J Sessle; B E Cairns; K Wang
Journal:  Eur J Pain       Date:  2007-12-26       Impact factor: 3.931

Review 10.  Ion channels and osteoarthritic pain: potential for novel analgesics.

Authors:  C A Staunton; R Lewis; R Barrett-Jolley
Journal:  Curr Pain Headache Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.